Comparative absorption profiles of divalproex sodium delayed-release vs. extended-release tablets-clinical implications

被引：0
|
作者：
Dutta, S
Reed, RC
O Dea, R
机构：
来源：
NEUROLOGY | 2005年 / 64卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A189 / A190
页数：2
相关论文
共 50 条
  • [21] CLINICAL RESPONSES AND SYMPTOMATIC REMISSIONS ACHIEVED WITH DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE IN CHILDREN WITH ADHD
    Childress, Ann C.
    Wigal, Sharon B.
    Marraffino, Andrea
    DeSousa, Norberto J.
    Incledon, Bev
    Sallee, Floyd R.
    Cutler, Andrew J.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10): : S286 - S287
  • [22] Comparison of the bioavailability of 250 and 500 mg divalproex sodium extended-release tablets in healthy volunteers
    Dutta, S
    Zhang, YM
    Lee, LL
    O'Dea, R
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 2004, 25 (08) : 353 - 357
  • [23] Conversion from delayed-release sodium valproate to extended-release sodium valproate in a moderately mentally retarted pediatric population
    Scully, Audrey
    Conry, Joan A.
    Kolodgie, Marian J.
    Renuart, Andrew
    Sigman, Michael
    Salpekar, Jay
    [J]. EPILEPSIA, 2006, 47 : 184 - 185
  • [24] Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed-Release and Extended-Release Methylphenidate: In Vivo, In Vitro, and Modeling Evaluations
    Incledon, Bev
    Incledon, Chantal
    Gomeni, Roberto
    Uchida, Cassandra L.
    Morris, Amy
    Perry, Kim
    Kapuscinski, Jill
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (08): : 966 - 975
  • [25] Once-daily dosing is appropriate for extended-release divalproex over a wide dose range, but not for enteric-coated, delayed-release divalproex: Evidence via computer simulations and implications for epilepsy therapy
    Reed, Ronald Charles
    Dutta, Sandeep
    Liu, Wei
    [J]. EPILEPSY RESEARCH, 2009, 87 (2-3) : 260 - 267
  • [26] IMPROVEMENTS IN EMOTIONAL LABILITY WITH DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE TREATMENT IN CHILDREN WITH ADHD
    Arnold, Valerie
    Lopez, Frank
    Childress, Ann
    Po, Michelle
    Gregg, Ryan
    Sallee, Floyd
    Incledon, Bev
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 60 (10): : S257 - S257
  • [27] Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit
    Boggs, JG
    Preis, T
    [J]. EPILEPSIA, 2005, 46 (06) : 949 - 951
  • [28] Extended-release divalproex sodium improves the quality of life of adolescent migraineurs
    Mendizabal, JE
    [J]. HEADACHE, 2002, 42 (04): : 327 - 328
  • [29] Once-daily dosing, over a large dose range, is appropriate for extended-release divalproex, but not for enteric-coated, delayed-release divalproex: Evidence via computer simulations and implications for epilepsy therapy
    Reed, Ronald C.
    Dutta, Sandeep
    [J]. EPILEPSIA, 2006, 47 : 196 - 197
  • [30] Assessment of patient preference and side effects in patients switched from divalproex sodium delayed release to divalproex sodium extended release
    Minirth, FB
    Neal, V
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (01) : 99 - 101
12345